A laser endoscopy system was developed in 2012. The system allows blue laser imaging (BLI), BLI-bright, and linked color imaging (LCI) to be performed as modes of narrowband light observation; these modes have been reported to be useful for tumor detection and characterization. Furthermore, an innovative endoscopy system using four-light emitting diode (LED) multilight technology was released in 2016 to 2017 in some areas in which laser endoscopes have not been approved for use, including the United States and Europe. This system enables blue light imaging (this is also known as BLI) and LCI with an LED light source instead of a laser light source. Several reports have shown that these modes have improved tumor detection. In this paper, we review the efficacy of BLI and LCI with laser and LED endoscopes in tumor detection and characterization. (Gut Liver 2019;13:140-148 ) 
INTRODUCTION
According to the World Health Organization (WHO), colorectal cancer (CRC) was the third-most common type of cancer with regard to morbidity and had the fourth highest rate of mortality among all cancers in 2012. 1 In Japan, there were 149,500 cases and 53,000 deaths among a population of 126 million in 2017, making CRC the most common type of cancer with regard to morbidity and the second-most common cause of cancer-related death-and the incidence is still increasing. 2 Due to the aging of the population, the incidence of CRC and the number of colonoscopy procedures are expected to increase in the future. The effective tumor detection, accurate diagnosis, and treatment of tumors are important for reducing the rate of CRC death. For these reasons, a light amplification by stimulated emission of radiation (LASER) endoscopic system (LASEREO; Fujifilm Co., Tokyo, Japan) was developed in 2012. 3 The system allows for blue laser imaging (BLI), BLI-bright, and linked color imaging (LCI) to be performed as modes of narrow-band light observation; these modes have been reported to be useful for tumor detection and characterization. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Furthermore, an innovative endoscopy system using four-light emitting diode (LED) multilight technology (Fujifilm Co.) was released in 2016 to 2017 for some areas in which LASER endoscopes have not been approved for use, including the United States and Europe. 19 This system enables blue light imaging (this is also called as BLI) and LCI with an LED light source instead of a LASER light source. In this paper, we review the efficacy of BLI and LCI with LASER and LED endoscopes in colorectal tumor detection and characterization.
THE CHARACTERISTICS OF LASER AND LED ENDO-SCOPES
The new endoscope system "LASEREO," which was developed by Fujifilm, uses a semiconductor LASER as a light source. It has a narrow-band light observation function without a customized optical filter. The LASEREO system consists of a light source (LL-7000), a processor (VP-7000), and a series of special This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. detecting tumors.
On the other hand, high-intensity illumination based on 4-LED Multi Light technology (BL-7000) provides high-quality images with white light and new observation modes of BLI and LCI. The system has four types of light: blue-violet, blue, green, and red (Fig. 1) . 19 
COLORECTAL TUMOR CHARACTERIZATION
NBI and pit pattern observation are the gold standard for tumor characterization. 20, 21 BLI magnification is also regularly used to this end as well. This enables us to clearly observe the surface structures and vessel patterns. 4, 5 Some reports have shown the efficacy of BLI magnification (Table 1) . [4] [5] [6] Our previous study compared BLI and NBI. Endoscopic images of surface structures and vessel patterns obtained using BLI magnification were slightly different from those obtained with NBI magnification ( Fig. 2) . 4 In detail, 104 colorectal neoplasms were examined with both BLI and NBI magnification. The Hiroshima classification was an NBI classification and was used to assess the surface structures and vessel patterns observed with NBI magnification in that study. 22 The diagnostic accuracy of BLI magnification in the NBI classification was 74.0% (77/104), which was similar to that of NBI magnification (77.8%). The rate of consistency between BLI and NBI magnification in the NBI classification was 74.0%. Another study from our group showed that the diagnostic accuracy of BLI magnification was 84.3% among 314 polyps (hyperplastic polyps and sessile serrated polyps [SSP], n=41; low-grade adenoma, n=168; high-grade adenoma, n=80; T1 cancer, n=25) using the Hiroshima classification. 5 The accuracy of differentiation between non-neoplastic and neoplastic lesions was 99.3% (312/314), while that between adenomatous and cancerous lesions was 85.0% (232/273). The diagnostic accuracy for polyps <20 mm in diameter was better than that for polyps ≥20 mm in diameter (92.1% vs 72.5%, p<0.001). The diagnostic accuracy with regard to the morphology was significantly lower for superficial polyps of ≥20 mm in diameter than for superficial polyps of <20 mm in diameter (70.0% vs 82.9%, p=0.03). In addition, the diagnostic accuracy of BLI without magnification for differentiating between neoplastic and non-neoplastic polyps <10 mm in diameter was 95.2%, which was greater than that of white light (83.2%).
The diagnostic accuracy of BLI magnification and pit pattern observation was compared in a previously published study. 6 The diagnostic accuracy for the differentiation of neoplastic from non-neoplastic lesions was 98.4% with BLI and 98.7% with pit pattern observation. In addition, the diagnostic accuracy of BLI magnification for T1b cancers was 89.5%, while that of pit pattern observation was 92.1%. The study further suggested that pit pattern observation should be performed for lesions with severely irregular surface structures and vessel patterns on BLI in order to improve the diagnostic accuracy. Recently, the Japan NBI Expert Team (JNET) classification has been reported to be useful for differentiating between ad- enoma, high-grade dysplasia, and T1b cancer (Fig. 3) . 20 While it was originally performed with NBI, the JNET classification can also be performed with BLI; we previously demonstrated high consistency in the findings of NBI and BLI magnification as described above. 4 On the other hand, no studies have reported the efficacy of BLI with LED endoscopes with or without magnification for tumor characterization. In our experience, LEDs and LASERs are almost similar; however, LED light is generally a little brighter than LASER light. We believe that the various classifications used in BLI with a LASER endoscope can also be used in BLI with an LED endoscope (Fig. 4) . In a BASIC study, a European group proposed that BLI with an LED light source could be used to differentiate non-neoplastic lesions from neoplastic ones based on the surface characteristics (presence of mucus, regular/ irregular, presence of depression), pit pattern (featureless, type, round with or without dark spots, homogenous distribution or heterogenous one), and vessel characteristics (presence, lacy, pericryptal, irregular). 19 The accuracy of this classification is currently being examined. Regarding SSP, two previously reported endoscopic findings detected by NBI magnification can be used:
thick and branched vessels and expanded crypt opening (Fig. 5) . 23 A unique method of observation combining LCI with a LASER light source and crystal violet dyeing was reportedly applied in a small number of cases (Table 1) . 7 This approach improved the contrast of the pit pattern, allowing the endoscopist to determine whether or not it had been destroyed (Fig. 6) . Another unique study from China showed that LCI with a LASER light source enabled NICE classification. 
COLORECTAL TUMOR DETECTION
The removal of adenomas by colonoscopy has been proven to reduce the incidence of CRC and CRC-related death. [24] [25] [26] However, it was reported that 20% to 27% of polyps were missed by WLI. 27, 28 Various factors have been reported to be associated with an increased risk of missing polyps, including a flat morphology, small size, presence in the ascending colon, male sex, multiple polyps at the time of first colonoscopy, and a history of polyps. 29, 30 BLI-bright is brighter than BLI and is expected to show improved rates of tumor detection. For colorectal tumors, BLIbright makes a neoplastic lesion appear brownish in color, facilitating their detection. Our previous study on polyp visibility was performed with short movies of polyps recorded with BLIbright and WLI and an original polyp visibility scoring system (score 4, excellent visibility; score 3, good; score 2, fair; score 1, poor). 8 In the movies of 100 whole neoplastic and non-neoplastic polyps, BLI-bright achieved higher scores than WLI (experts: 3.10±0.95 vs 2.90±1.09, p=0.00013; non-experts: 3.04±0.94 vs 2.78±1.03, p<0.0001) (Fig. 7) . In addition, a subgroup analysis of experts only showed that the mean visibility score of BLIbright mode was significantly higher than that of WLI for flat polyps, neoplastic polyps, and polyps located in the left-sided colon and rectum.
There have been some randomized controlled trials (RCTs) for detection using BLI (Table 2) . Our previous multicenter RCT showed that BLI-bright (n=489) resulted in a greater mean number of adenomatous polyps detected per patient than WLI (n=474) (1.27±1.73 vs 1.01±1.36, p=0.008) and also improved the mean total number of polyps per patient compared with WLI (1.84±2.09 vs 1.43±1.64, p=0.001). 9 However, BLI-bright required a longer observation times than WLI (9.5±3.8 minutes vs 8.4±2.9 minutes, p<0.001). Another RCT in which patients were randomized to one of two tandem colonoscopy groups (BLI followed by WLI or WLI followed by BLI) showed that the polyp miss rate in the BLI-WLI group was 1.6%, which was significantly lower than that in the WLI-BLI group (10.0%, p=0.001).
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BLI-bright observation is not widely accepted; however, there have been some positive reports, as described above. There are two major limitations regarding the use of BLI-bright. First, the residual liquid becomes reddish, which disturbs the endoscopic view. Second, the endoscopic view of BLI-bright is darker than with WLI, and NBI has the same problems. LCI has the potential to resolve these problems because it is brighter than BLI and BLI-bright and because the residual liquid becomes yellowish with LCI (Fig. 8) . We previously reported that LCI improved the polyp visibility score using endoscopic movies. 12 Among the LCI, BLI-bright, and WLI movies of 101 colorectal polyps, the mean polyp visibility scores of LCI (2.86±1.08) were higher than 12 Another study that we performed using endoscopic images showed the efficacy of LCI in the observation of diminutive polyps (<5 mm in size). 13 In that study, the color difference values between the tumor and the surrounding mucosa were calculated among endoscopic images of 54 colorectal polyps obtained by WLI and LCI in order to evaluate polyp visibility. The color difference value is thought to be an objective indicator of the polyp visibility. That study showed that LCI improved the color difference values more than WLI (33.6±13.9 vs 20.7±13.6, p<0.001) (Fig. 9) . A similar study using polyp visibility scores showed that LCI improved the endoscopic visualization of nongranular colorectal lesions and also demonstrated the efficacy of LCI in the observation of SSPs.
14 Several studies have shown the usefulness of LCI in polyp detection (Table 2) . A Chinese RCT proved that LCI increased the adenoma detection rate (ADR) (LCI vs WLI, 37% vs 28%; 95% confidence interval, 2.3% to 19.4%) ( Table 2) . 15 That same study also revealed that LCI resulted in significantly improved rates of adenoma and SSP detection compared with WLI (91% vs 73%, p<0.001). A Japanese RCT of LCI showed that the polyp detection rate of 6 non-expert endoscopists (92.3%±2.9%) was significantly higher than with WLI (72.7%±11.5%, p<0.01) for observations from the cecum to splenic flexure. 16 Furthermore, in a tandem endoscopy setting, the SSP detection rate of the LCI group (21.6%, 8/37) was significantly higher than that of the LCI-WLI group (3.2%, 1/31; p=0.02). A European RCT of LCI with LED showed a significant difference in the adenoma miss rate in the right sided colon (cecum and ascending colon) between WLI and LCI (30.6% vs 11.8%, p<0.001). 17 Furthermore, in our previous study, an additional 30-second observation with LCI after WLI observation was found to significantly improve the overall adenoma and SSP numbers compared with a second observation with WLI after initial WLI. 18 In that study the cecum and ascending colon were observed with WLI first in all cases, after which the colonoscope was inserted again, and the cecum and ascending colon were observed for an additional 30 seconds using either LCI or WLI. In this additional 30-second observation, the cecum and ascending colon were sufficiently insufflated and observed from a distant view. The overall adenoma and SSP numbers in the first and second observations of the LCI and WLI groups were 48 and 36, respectively (p=0.02). In addition, in the LCI group, the number of adenomas and SSPs in the first and second observations were significantly higher than in the first observation (48 vs 35, p=0.017). However, one limitation associated with LCI involved issues with halation in the endoscopic view due to the high brightness, which might lead to missed polyps.
CONCLUSIONS
BLI with or without magnification and LCI without magnification with a LASER endoscope are more effective for polyp characterization than other approaches. BLI with a LASER endoscope and LCI with a LASER or LED endoscope are particularly useful for polyp detection. The BLI and LCI images obtained with a LASER endoscopy were considered to be almost similar to those obtained with an LED endoscope.
